Resources

Latest news & updates.

Company announcements, clinical publications, and product milestones from PainTEQ.

Jul 2026

PainTEQ Presents New Scientific Evidence Supporting Cortical-Piercing Posterior Sacroiliac Joint Procedures at ASPN 2026

Jun 2026

PainTEQ Announces First Patient Enrolled in the TRAQTION Study

May 2026

PainTEQ Launches TRAQ™, A Next-Generation Posterior Approach to SI Joint Fusion

Mar 2026

PainTEQ Wins Top VC/PE Honors in Tampa Bay

Jan 2026

PainTEQ Fuels Next Phase of Growth at NANS 2026 with Strategic Expansion of Innovation, Clinical Initiatives, and Product Portfolio

Jan 2026

PainTEQ Announces Appointment of Lalit Venkatesan, PhD as Senior Vice President of Clinical Research

Oct 2025

PainTEQ Scales Leadership: Med-Tech Catalyst Robert Kline Joins Board to Drive New Standard in Interventional Spine Care

Oct 2025

Largest Real-World Study Confirms Long-Term Safety and Efficacy of Minimally Invasive Posterior SI Joint Fusion Using Novel Cortical Allograft

Sep 2025

PainTEQ Announces Appointment of Mike Sherman to Its Board of Directors

Aug 2025

PainTEQ Secures Majority Growth Recapitalization Co-Led by Signet Healthcare Partners & Windham Capital Partners :

Dec 2024

PainTEQ Secures Groundbreaking Patent LINQ® Technology, Advancing Precision and Efficiency in SI Joint Fusion

May 2024

PainTEQ Receives Two New Patents for the LinQ® Procedure, Advancing Treatments for SI Joint Dysfunction

Mar 2024

Outcomes of a Posterior Approach to SI Joint Fusion with LinQ® Reflect Clinical Efficacy and Durability at 12 Months

Jan 2024

PainTEQ Announces Successful Completion of First In-office LinQ Procedure Under New CMS Billing Code

Dec 2023

Patent Trial and Appeal Board Sides with PainTEQ in the Orthocision IPR Case

Nov 2023

CMS Finalizes New Billing Code for Posterior SI Joint Fusion to Be In-office Procedure

Sep 2023

PainTEQ Launches World’s First Surgery-Ready Instruments for Posterior Approach with LinQ

Jul 2023

PainTEQ Raises $35 Million in Non-Dilutive IP-Backed Financing, Fueling Market Expansion and Innovation

Jun 2023

Comparative Analysis Concludes Posterior Approach to SI Joint Fusion is as Effective as the Lateral Approach

May 2023

PainTEQ Announces Decision from Patent Trial and Appeal Board in IPR Proceeding

Dec 2022

PainTEQ Expands Leadership Team with New Senior VP of Reimbursement and Market Access

Oct 2022

AMA Announces Category 1 Billing Code for Posterior SI Joint Fusion

Oct 2022

Cally Stanphill Accepted into Forbes Human Resources Council

Aug 2022

PainTEQ Ranked #149 on the Inc. 5000 List of Fastest-Growing Private Companies in America

Jun 2022

First-ever Prospective Evidence on Posterior Approach to SI Joint Fusion Reflects Improved Pain Scores at 6 Months

May 2022

LinQ Sacroiliac Joint Fusion Lab Demo | Ramana Naidu, MD

Apr 2022

Tampa-Based Medical Device Company, PainTEQ, Treats Employee’s Father With 100% Pain Relief 6-Months Post-Op

Jan 2022

Landmark Prospective Evidence on Posterior Approach to SI Joint Fusion Reflects Improved Pain Scores at 6 & 12 Months

Dec 2021

Biomechanical Evaluation of Novel Posterior Approach to SI Joint Fusion Yields Statistically Significant Results

Nov 2021

Michael Enxing Appointed President of PainTEQ

Oct 2021

Real-World Review of PainTEQ’s Minimally Invasive SI Joint Fusion Device Reports Long-Term Efficacy and Safety

Sep 2021

PainTEQ Acquires Three U.S. Patents for Innovative Sacroiliac (SI) Joint Procedure

Jun 2021

Get to Know LinQ: The Revolutionary SI Joint Procedure

Jun 2021

PainTEQ Featured on Business Observer Website

Jun 2021

PainTEQ Exceeds 75% Enrollment in Landmark SI Joint Fusion Study

Jun 2021

Back Care Awareness Week: Is your Back Pain Being Properly Treated?

Jun 2021

September is Pain Awareness Month – Could your back pain be caused by your SI joint?

Jun 2021

Shanth Thiyagalingam joins PainTEQ to lead commercialization of novel SI joint pain therapy

Jun 2021

PainTEQ Begins Novel Biomechanical Study on SI Joint Fusion

Jun 2021

Register for Webinar on Minimally Invasive Fusion with LinQ

Jun 2021

Michael Enxing joins PainTEQ Board of Directors

Jun 2021

PainTEQ Announces Landmark SI Joint Fusion Study

Jun 2021

Initial Experience with a Minimally Invasive Sacroiliac Fusion Device, a Retrospective Case Series